GLP-1 medications, like all prescription treatments, carry potential side effects that should be monitored and discussed with a qualified provider throughout the course of care
Even though more than 50% of patients experienced side effects, mainly gastrointestinal symptoms, it required stopping semaglutide use or dose mitigation in only ~16% of the patients, showing that this drug is well-tolerated, which is crucial for chronic weight management
Thymalin primarily supports immune regulation, stem cell activity, and healthy aging
There is no one-size-fits-all operation
Participants received once-daily subcutaneous sermorelin at 30 g/kg administered at bedtime for up to one year, with height velocity assessed as the primary efficacy endpoint
Instead of continuing full therapeutic doses, the goal of maintenance is to: Keep appetite and cravings stable Support metabolic balance Prevent rapid rebound weight gain Allow your body to adjust gradually Why GLP-1 Maintenance Matters GLP-1 medications work at multiple levels: blood sugar regulation, appetite signaling, digestion speed, insulin release, and even reward-based eating patterns